ArticleInternational journal of molecular sciences2021

Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells.

Rouven Arnold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.